Fifth Circuit's Decision on Workers' Comp Could Shape Fraud Cases
The Fifth Circuit reviews if workers' comp is a 'health care benefit' in fraud cases.
Why it matters: This review could redefine legal strategies in fraud cases involving workers' benefits, impacting both healthcare sector policies and corporate legal assessments.
- Fifth Circuit re-evaluates workers' comp status in fraud prosecution strategy.
- Texas pharmacy owners linked to $158M fraud and sentenced to extensive terms.
- Court orders defendants to repay $115 million and forfeit $405 million in assets.
- OWCP's $321M overspending prompts major oversight revisions by Department of Labor.
The United States Court of Appeals for the Fifth Circuit is poised to decide whether workers' compensation qualifies as a "health care benefit" in cases of alleged fraud. This determination emerges from a high-profile case involving two Texas pharmacy owners accused of orchestrating a multi-million dollar fraud scheme.
Specifically, these owners received prison sentences of 210 and 180 months after participating in a $158 million scheme tied to compounded drug prescriptions. They have been instructed to repay $115 million and relinquish assets totaling $405 million, a verdict underscored by reporting from the Department of Labor.
Repercussions from this case extend to the Office of Workers’ Compensation Programs (OWCP), which reported a $321 million overspending on drug costs between FY 2015 and FY 2020. In response, the Department of Labor has revamped oversight, particularly focusing on the Pharmacy Benefit Manager's operations, according to their comprehensive review.
This ruling bears significant implications for how federal fraud cases may evolve, particularly in redefining how programs like workers' comp are prosecuted. Legal professionals in corporate and healthcare sectors should stay updated, as adjustments may be necessary for compliance and litigation strategies.
By the numbers:
- $158 million — Fraud scheme involving compounded drug prescriptions.
- $115 million — Amount to be repaid by convicted pharmacy owners.
- $321 million — OWCP overspending prompting oversight changes.
What's next: The Fifth Circuit's decision will set a precedent for future fraud litigation strategies.